Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma

Annals of Oncology

Volumn 15, Issue 11, 2004, Pages 1667-1672

  Grobmyer, S R ^a   Maki, R G ^a   Demetri, G D ^a   Mazumdar, M ^b   Riedel, E ^b   Brennan, M F ^a   Singer, S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Doxorubicin; Ifosfamide; Neo adjuvant; Sarcoma

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; MESNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; LIMB TUMOR; MAJOR CLINICAL STUDY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; EXTREMITIES; HUMANS; IFOSFAMIDE; MESNA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 9444228341     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh431     Document Type: Article

References (22)

1. Brennan MF, Alektiar KM, Maki RG. Soft Tissue Sarcoma. In DeVita VT, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, 6th edition. Philadelphia, PA: Lippincott, Williams, and Wilkins 2001; 1841-1890.
2. Singer S, Demetri GD, Baldini EH, Fletcher CD. Management of soft-tissue sarcomas: an overview and update. Lancet Oncol 2000; 1: 75-85.
3. Crist W, Gehan EA, Ragab AH et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995; 13: 610-630.
4. Raney RB, Asmar L, Newton WA Jr et al. Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol 1997; 15: 574-582.
5. Eilber FC, Rosen G, Eckardt J et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001; 19: 3203-3209.
6. Meric F, Hess KR, Varma DG et al. Radiographic response to neo-adjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer 2002; 95: 1120-1126.
7. Hajdu S. Pathology of Soft Tissue Tumors. Philadelphia, PA: Lea and Febiger 1979.
8. Pisters PW, Harrison LB, Leung DH et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 1996; 14: 859-868.
9. Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol 2003; 15: 319-326.
10. Greenall MJ, Magill GB, DeCosse JJ, Brennan MF. Chemotherapy for soft tissue sarcoma. Surg Gynecol Obstet 1986; 162: 193-198.
11. Demetri GD, Elias AD. Results of single-agent and combination chemotherapy for advanced soft fissue sarcomas. Implications for decision making in the clinic. Hematol Oncol Clin North Am 1995; 9: 765-785.
12. Sarcoma Meta-analysis Collaboration. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet 1997; 350: 1647-1654.
13. Verweij J, Seynaeve C. The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting. Semin Radiat Oncol 1999; 9: 352-359.
14. Edmonson JH, Ryan LM, Blum RH et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993; 11: 1269-1275.
15. Gortzak E, Azzarelli A, Buesa J et al. A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur J Cancer 2001; 37: 1096-1103.
16. Brodowicz T, Schwameis E, Widder J et al. Intensified adjuvant IFA-DIC chemotherapy for adult soft tissue sarcoma: a prospective randomized feasibility trial. Sarcoma 2000; 4: 151-160.
17. Frustaci S, Gherlinzoni F, De Paoli A et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001; 19: 1238-1247.
18. Judson I. Adjuvant chemotherapy of soft-tissue sarcoma - current status. Sarcoma 2000; 4: 149-150.
19. Bramwell VH. Adjuvant chemotherapy for adult soft fissue sarcoma: is there a standard of care. J Clin Oncol 2001; 19: 1235-1237.
20. Frustaci S, De Paoli A, Bidoli E et al. Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 2003; 65: 80-84.
21. DeLaney TF, Spiro IJ, Suit RD et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2003; 56: 1117-1127.
22. Grobmyer SR, Maki R, Demetri GD et al. Neo-adjuvant chemotherapy for primary high grade extremity soft tissue sarcomas: A matched case control study. Proc Am Soc Clin Oncol 2003; 122: 815.